<DOC>
	<DOCNO>NCT00271869</DOCNO>
	<brief_summary>Chronic graft-versus-host disease ( GVHD ) major complication allogeneic hematopoietic stem cell transplantation lead cause death 2 year transplantation.During past 30 year survival patient chronic GVHD improve steroid remain often use therapy . Extracorporeal photoimmunotherapy ( ECP ) show efficacious patient GVHD . We propose phase II study evaluate safety efficacy ECP adjunct first-line therapy patient newly diagnose chronic GVHD liver lung need systemic immunosuppression define accord NIH consensus criterion .</brief_summary>
	<brief_title>Treatment Chronic GVHD Liver Lungs ECP</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>Presence least one diagnostic clinical sign chronic GVHD appropriate constellation distinctive sign confirm biopsy relevant diagnostic test Presence liver lung manifestation chronic GVHD Indication systemic immunosuppressive therapy define accord NIH consensus No prior immunosuppressive therapy chronic GVHD liver lung Adequate renal , hepatic , pulmonary cardiac function Karnofsky performance score &gt; 50 % Women childbearing potential must agree use reliable method birth control duration study Signed write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2005</verification_date>
	<keyword>hematopoietic stem cell transplantation</keyword>
	<keyword>graft-versus-host disease</keyword>
	<keyword>treatment</keyword>
</DOC>